KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Ginkgo Bioworks Holdings (DNA) Shares Outstanding (2019 - 2025)

Ginkgo Bioworks Holdings filings provide 7 years of Shares Outstanding readings, the most recent being $58.2 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 0.68% to $58.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $58.2 million, a 0.68% increase, with the full-year FY2025 number at $58.2 million, up 0.68% from a year prior.
  • Shares Outstanding hit $61.7 million in Q4 2025 for Ginkgo Bioworks Holdings, up from $56.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $2.0 billion in Q2 2023 to a low of $408497.0 in Q3 2021.
  • Median Shares Outstanding over the past 5 years was $56.1 million (2025), compared with a mean of $600.5 million.
  • Biggest five-year swings in Shares Outstanding: rose 26.45% in 2022 and later tumbled 97.37% in 2024.
  • Ginkgo Bioworks Holdings' Shares Outstanding stood at $40.3 million in 2021, then grew by 17.41% to $47.3 million in 2022, then increased by 5.78% to $50.0 million in 2023, then grew by 15.55% to $57.8 million in 2024, then increased by 0.68% to $58.2 million in 2025.
  • The last three reported values for Shares Outstanding were $58.2 million (Q4 2025), $60.3 million (Q3 2025), and $55.4 million (Q2 2025) per Business Quant data.